Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchase
BOLD•Kevin Tang increases indirect stake in Boundless Bio
- Kevin Tang, 10% owner, increased an indirect stake in Boundless Bio through open-market purchases at USD 2.43 to USD 2.44.
- Indirect beneficial ownership rose to 2,854,072 Boundless Bio common shares.
